These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1503451)

  • 1. In vitro susceptibilities of Mycoplasma genitalium to antibiotics.
    Renaudin H; Tully JG; Bebear C
    Antimicrob Agents Chemother; 1992 Apr; 36(4):870-2. PubMed ID: 1503451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative susceptibilities of various AIDS-associated and human urogenital tract mycoplasmas and strains of Mycoplasma pneumoniae to 10 classes of antimicrobial agent in vitro.
    Hannan PC
    J Med Microbiol; 1998 Dec; 47(12):1115-22. PubMed ID: 9856648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turning the Tide against Antibiotic Resistance by Evaluating Novel, Halogenated Phenazine, Quinoline, and NH125 Compounds against
    Valentine-King MA; Cisneros K; James MO; Huigens RW; Brown MB
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro sensitivity to antibiotics in 178 strains of genital mycoplasma isolated from gynecology consultants in Dakar].
    Sow AI; Diallo Y; el Hadi AD; Samb A
    Bull Soc Pathol Exot; 2000 Feb; 93(1):6-7. PubMed ID: 10774483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp.
    Duffy LB; Crabb D; Searcey K; Kempf MC
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():29-33. PubMed ID: 10824029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of several antimicrobial agents against genital mycoplasmas.
    Echániz Avilés G; Conde González C; Juárez Figueroa L; Carnalla Barajas N; Tamayo Legorreta E; Calderón Jaimes E
    Clin Ther; 1992; 14(5):688-95. PubMed ID: 1468088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of trospectomycin sulphate against Mycoplasma and Ureaplasma species isolated from humans.
    Yancey RJ; Klein LK
    J Antimicrob Chemother; 1988 Jun; 21(6):731-6. PubMed ID: 2970452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to a new quinolone, OPC 17116.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1726-7. PubMed ID: 8215294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibilities of Mycoplasma putrefaciens field isolates.
    Antunes NT; Tavío MM; Mercier P; Ayling RD; Al-Momani W; Assunção P; Rosales RS; Poveda JB
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3452-4. PubMed ID: 17638695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2604-8. PubMed ID: 11502536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2628-32. PubMed ID: 7872759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolide susceptibility of Mycoplasma hyorhinis isolated from piglets.
    Kobayashi H; Morozumi T; Munthali G; Mitani K; Ito N; Yamamoto K
    Antimicrob Agents Chemother; 1996 Apr; 40(4):1030-2. PubMed ID: 8849222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro activity of sparfloxacin against mycoplasmas].
    Renaudin H; Bebear C
    Pathol Biol (Paris); 1992 May; 40(5):450-4. PubMed ID: 1323094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas.
    Waites KB; Crabb DM; Bing X; Duffy LB
    Antimicrob Agents Chemother; 2003 Jan; 47(1):161-5. PubMed ID: 12499185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotic sensitivity of Mycoplasma pathogenic for man].
    Quentin C; Cantet P; Renaudin H; Bebear C
    Pathol Biol (Paris); 1985 Mar; 33(3):205-12. PubMed ID: 3892448
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Waites KB; Crabb DM; Xiao L; Duffy LB
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.
    Waites KB; Cassell GH; Canupp KC; Fernandes PB
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1500-2. PubMed ID: 2973283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219).
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1996 Apr; 40(4):1048-9. PubMed ID: 8849228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas.
    Hannan PC; Woodnutt G
    J Antimicrob Chemother; 2000 Mar; 45(3):367-9. PubMed ID: 10702559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro antimicrobial activities of new quinolone antibiotics against Mycoplasma pneumoniae].
    Gohara Y; Arai S; Kuwano K; Kawashima T; Matsu-Ura I
    Nihon Saikingaku Zasshi; 1992 Mar; 47(2):387-93. PubMed ID: 1318981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.